Benzinga's Top Pre-Market Gainers

Supernus Pharmaceuticals SUPN surged 26.09% to $7.20 in the pre-market session. Supernus Pharmaceuticals received a tentative approval letter from the FDA for Trokendi XR(TM). News Corp NWSA added 5.05% to $21.10 in the pre-market session. News Corp is reportedly considering splitting into two companies. Arena Pharmaceuticals ARNA moved up 4.40% to $9.60 in the pre-market session. Arena Pharmaceuticals shares have jumped 586.57% over the past 52 weeks, while the S&P 500 index has gained 1.31% in the same period.. Apollo Group APOL soared 3.94% to $33.75 in the pre-market trading. Apollo Group reported better-than-expected FQ3 profit.